So, how long before we see Lipitor XR?
Started by rph3664
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
Lipitor already has a long half-life. There would really be no need for an XR version but hey, this is America and we're all about charging out the ass for useless drugs.
Not so sure about XR, maybe ODT? Or make it even simpler, just make a Lipitor Capsule. It's cool though, if you can't afford your medication, Pfiser may be able to help.
Perhaps Lipitor/<whatever anti-hypertensive> combo? Maybe Lipitor/Metformin? Why stop there, Lipitor/ezetimibe anyone? Or if they want to be really clever, Lipitor/Fish Oil. Really the possibilities are endless.
Perhaps Lipitor/<whatever anti-hypertensive> combo? Maybe Lipitor/Metformin? Why stop there, Lipitor/ezetimibe anyone? Or if they want to be really clever, Lipitor/Fish Oil. Really the possibilities are endless.
Advertisement - Members don't see this ad
Yea, I was going to say isn't Lipitor already once a day? ODT would be nice though!!! lol
Sure, why not?
Diabetes and hyperlipidemia go together like PB&J, I don't see the problem. 😕 Perhaps I am missing something though...
How about a vodka/metformin suspension? Lets induce a little lactic acidosis.
Once weekly lipitor
.......or a Lipitor patch.......Lipitor suppositories.......Lipitor nasel spray.......
Considering I can count the amount of times I've seen Caduet dispensed on one hand, I doubt they'll head this route.
You make a good point. I wonder how many suckers they need to make it worth their effort though?
What about Lipitor HD? http://www.iwanttobeapharmacist.com/2010/07/introducing-lipitor-hd.html
I was thinking they'd go the pristiq route and do DesAtorvastatin. Look, no affect on liver.
Advertisement - Members don't see this ad
D
deleted205891
Actually lipitor/fenofibrate wouldn't be too bad. I imagine they'll come up with lipitor/some kind of ARB since both are expensive if brand-name and an ACE or ARB is indicated with a statin for a lot of things.
And when you consider how often fenofibrate gets reformulated, that wouldn't surprise me either. 🙄 And you know it will be some wonky dose like 16mg atorvastatin/38mg fenofibrate.
They have actually applied to the FDA for Lipitor to be OTC. It won't happen but just shows they are willing to try anything - Pfizer has really gone all out trying to capture revenue these next 6 months. They project 40% over 6 months with all of their efforts, usually when a product goes generic it goes down to ~10%.
Its because they have cut deals with all the major insurance companies to make the copay on Lipitor less than the generic. FDA is letting Ranbaxy ship the generic starting tomorrow.
It's all in jest. Not only would they likely have already rolled it out, but the other mfgs would have done so when their patents were expiring as well.
I do like Atorvasartan.
I've heard discussion about Zocor becoming OTC for at least 10 years; statins are OTC, or at least behind the counter, in some European countries.
It is not a disease that can be self-diagnosed or effectively self-treated. It makes no sense as an OTC product. Not that I am saying you are wrong, only that I don't see it happening here.
My guess is they're going the Primatene Mist route. You technically should have an asthma diagnosis to buy it, but it is OTC. Monitoring is problematic though.
Have you never heard of Paxil CR?
I don't understand why we have both Watson and Ranbaxy. What happened to 6 month exclusive generic?
Advertisement - Members don't see this ad
Lets be realistic... it will combo with Niacin Er, call it Atorvacor. Make a weak research against monotherapy against statin monotherapy or niacin monotherapy, maybe even simcor, have great results (it will probably be an unfair dosage,like Lipitor 20mg vs Simvastatin 20mg). It will be the next big thing, true story.
Last edited:
Or just "reformulate" and come out with different strengths (5, 30, 60?) ala Tricor circa 2005?
"Authorized" generic. Brilliant move by the manufacturer.
The efficiency (or at times lack thereof) of our intellectual property rights system in medicine and elsewhere (patent wars anyone?) is a fun source of mockery overlaying a much deeper issue. These sorts of possibilities really require policy reform and not just criticism of drugmakers- they could care less (and this includes the millions of shareholders) and with due reason.
As for Lipitor, right now it looks like Pfizer is looking at more of a pricing strategy than re-releasing similar, but slightly different or combo medication (probably because the potential combos aren't financially viable). http://www.nytimes.com/2011/11/30/h...ts-off-an-aggressive-push-by-pfizer.html?_r=1
As for Lipitor, right now it looks like Pfizer is looking at more of a pricing strategy than re-releasing similar, but slightly different or combo medication (probably because the potential combos aren't financially viable). http://www.nytimes.com/2011/11/30/h...ts-off-an-aggressive-push-by-pfizer.html?_r=1
